神经重症监护服务与成人脑损伤患者死亡率和功能结局的关联:系统综述与meta分析
该系统综述与meta分析纳入26项非随机观察性研究,比较神经重症监护与常规监护对成人急性脑损伤ICU患者结局的影响。汇总55 792例患者,神经重症监护与全因死亡率相对风险降低17%相关(RR 0.83,95%CI 0.75-0.92,P=.001),8项研究(4667例)显示功能结局不良风险降低17%(RR 0.83,95%CI 0.70-0.97,P=.03),住院时间无差异,但异质性大,证据置信度有限。
要点
- 神经重症监护与成人脑损伤ICU患者全因死亡率相对风险降低17%相关(RR 0.83,95%CI 0.75-0.92,P=.001)。
- 神经重症监护与不良功能结局相对风险降低17%相关(RR 0.83,95%CI 0.70-0.97,P=.03)。
- ICU住院时间和住院总时间等住院时间结局在两组间无差异。
核心结论
- 专科神经重症监护与成人脑损伤危重患者生存率和功能结局改善相关,但异质性大限制证据置信度,需进一步研究确定神经重症监护中改善结局的具体方面及其成本效益。
研究设计与样本
- 研究方案在PROSPERO预注册(CRD42020177190),检索Ovid MEDLINE、Embase和Cochrane对照试验中心注册库从建库至2021年12月15日,并辅以引文追溯。
- 纳入26项非随机观察性研究,比较神经重症监护病房、神经重症医师或神经重症会诊服务与常规监护在神经疾病成人或ICU急性脑损伤成人中的效果。
- 数据按PRISMA指南提取,由两名独立评价者使用ROBINS-I Cochrane工具评估偏倚风险,采用随机效应模型合并数据。
主要发现
- 筛查5659条非重复发表记录后,纳入26项非随机观察性研究。
- 55 792例患者死亡率meta分析显示,接受专科监护者(n=27 061)较常规监护者(n=27 694)相对风险降低17%(RR 0.83,95%CI 0.75-0.92,P=.001)。
- 亚组分析未发现亚组间差异。
- 8项研究包括4667例患者,专科监护较常规监护不良功能结局相对风险降低17%(RR 0.83,95%CI 0.70-0.97,P=.03)。
- 住院时间结局无差异。
局限性
- 所有分析中异质性均较大,限制证据置信度。
- 需进一步研究以确定神经重症监护中改善结局的具体方面及其成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Neurocritical care (NCC) aims to improve the outcomes of critically ill patients with brain injury, although the benefits of such subspecialized care are yet to be determined. OBJECTIVE: To evaluate the association of NCC with patient-centered outcomes in adults with acute brain injury who were admitted to intensive care units (ICUs). The protocol was preregistered on PROSPERO (CRD42020177190). DATA SOURCES: Three electronic databases were searched (Ovid MEDLINE, Embase, Cochrane Central Register of Controlled Trials) from inception through December 15, 2021, and by citation chaining. STUDY SELECTION: Studies were included for interventions of neurocritical care units (NCCUs), neurointensivists, or NCC consulting services compared with general care in populations of neurologically ill adults or adults with acute brain injury in ICUs. DATA EXTRACTION AND SYNTHESIS: Data extraction was performed in keeping with PRISMA guidelines and risk of bias assessed through the ROBINS-I Cochrane tool by 2 independent reviewers. Data were pooled using a random-effects model. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality at longest follow-up until 6 months. Secondary outcomes were ICU length of stay (LOS), hospital LOS, and functional outcomes. Data were measured as risk ratio (RR) if dichotomous or standardized mean difference if continuous. Subgroup analyses were performed for disease and models of NCC delivery. RESULTS: After 5659 nonduplicated published records were screened, 26 nonrandomized observational studies fulfilled eligibility criteria. A meta-analysis of mortality outcomes for 55 792 patients demonstrated a 17% relative risk reduction (RR, 0.83; 95% CI, 0.75-0.92; P = .001) in those receiving subspecialized care (n = 27 061) compared with general care (n = 27 694). Subgroup analyses did not identify subgroup differences. Eight studies including 4667 patients demonstrated a 17% relative risk reduction (RR, 0.83; 95% CI, 0.70-0.97; P = .03) for an unfavorable functional outcome with subspecialized care compared with general care. There were no differences in LOS outcomes. Heterogeneity was substantial in all analyses. CONCLUSIONS AND RELEVANCE: Subspecialized NCC is associated with improved survival and functional outcomes for critically ill adults with brain injury. However, confidence in the evidence is limited by substantial heterogeneity. Further investigations are necessary to determine the specific aspects of NCC that contribute to these improved outcomes and its cost-effectiveness.
引用
- Pham X, Ray J, Neto AS, et al. Association of Neurocritical Care Services With Mortality and Functional Outcomes for Adults With Brain Injury: A Systematic Review and Meta-analysis. JAMA Neurol. 2022. PMID: 36036899. doi:10.1001/jamaneurol.2022.2456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。